Pfanstiel Steven
Insider CIK 1856059 · STIM Former EVP, CFO and Treasurer · MRNS Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| STIM Neuronetics, Inc. | S Sale | 2026-03-19 | 2026-05-21 | 8,569 | $1.34 | $11.5K | 836,643 | SEC↗ |
| STIM Neuronetics, Inc. | S Sale | 2026-03-19 | 2026-03-24 | 16,431 | $1.34 | $22.0K | 828,781 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2026-03-17 | 2026-03-18 | 25,000 | — | $0 | 845,212 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2026-02-23 | 2026-02-25 | 250,000 | — | $0 | 820,212 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2025-12-30 | 2025-12-31 | 170,212 | — | $0 | 570,212 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2025-07-15 | 2025-07-15 | 200,000 | — | $0 | 400,000 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2025-07-15 | 2025-07-15 | 200,000 | — | $0 | 200,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 57,300 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 114,600 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 126,585 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 74,475 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 220,000 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer | 2025-02-11 | 2025-02-11 | 62,470 | $0.55 | $34.4K | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer | 2025-02-07 | 2025-02-11 | 17,303 | $0.55 | $9.5K | 62,470 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2024-08-05 | 2024-08-07 | 4,657 | $1.13 | $5.3K | 79,773 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2024-06-18 | 2024-06-20 | 57,300 | — | $0 | 57,300 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2024-06-18 | 2024-06-20 | 12,733 | — | $0 | 84,430 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2024-02-16 | 2024-02-21 | 3,092 | $9.97 | $30.8K | 71,697 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2024-01-18 | 2024-01-19 | 114,600 | — | $0 | 114,600 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2024-01-18 | 2024-01-19 | 25,465 | — | $0 | 74,789 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2023-08-08 | 2023-08-08 | 14 | $8.93 | $125 | 49,324 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2023-08-07 | 2023-08-08 | 2,790 | $9.54 | $26.6K | 49,338 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2023-01-26 | 2023-01-30 | 126,585 | — | $0 | 126,585 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2023-01-26 | 2023-01-30 | 28,130 | — | $0 | 52,128 | SEC↗ |
| MRNS] MARINUS PHARMACEUTICALS, I | A Award | 2022-05-24 | 2022-05-26 | 7,448 | — | $0 | 23,998 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2022-02-04 | 2022-02-07 | 74,475 | — | $0 | 74,475 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award | 2022-02-04 | 2022-02-07 | 16,550 | — | $0 | 16,550 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2021-04-12 | 2021-04-13 | 220,000 | — | $0 | 220,000 | SEC↗ |